These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30982983)

  • 1. Sumoylation of PPARγ contributes to vascular endothelium insulin resistance through stabilizing the PPARγ-NcoR complex.
    Lan D; Shen X; Yuan W; Zhou Y; Huang Q
    J Cell Physiol; 2019 Nov; 234(11):19663-19674. PubMed ID: 30982983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of eNOS-NO signaling by over-SUMOylation of PPARγ contributes to insulin resistance and dysfunction of vascular endothelium in rats.
    Yuan W; Ma C; Zhou Y; Wang M; Zeng G; Huang Q
    Vascul Pharmacol; 2019; 122-123():106597. PubMed ID: 31479752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines.
    Jennewein C; Kuhn AM; Schmidt MV; Meilladec-Jullig V; von Knethen A; Gonzalez FJ; Brüne B
    J Immunol; 2008 Oct; 181(8):5646-52. PubMed ID: 18832723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMOylation and coupling of eNOS mediated by PIAS1 contribute to maintenance of vascular homeostasis.
    Wang L; Zeng W; Wang C; Lu Y; Xiong X; Chen S; Huang Q; Yan F; Huang Q
    FASEB J; 2024 Jan; 38(1):e23362. PubMed ID: 38102979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
    Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation of PPARγ by rosiglitazone prevents LPS-induced NCoR degradation mediating down regulation of chemokines expression in renal proximal tubular cells.
    Lu Y; Zhou Q; Shi Y; Liu J; Zhong F; Hao X; Li C; Chen N; Wang W
    PLoS One; 2013; 8(11):e79815. PubMed ID: 24260304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological activation of PPAR gamma ameliorates vascular endothelial insulin resistance via a non-canonical PPAR gamma-dependent nuclear factor-kappa B trans-repression pathway.
    Zhang Y; Zhan RX; Chen JQ; Gao Y; Chen L; Kong Y; Zhong XJ; Liu MQ; Chu JJ; Yan GQ; Li T; He M; Huang QR
    Eur J Pharmacol; 2015 May; 754():41-51. PubMed ID: 25687252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation.
    Xie B; Liu X; Yang J; Cheng J; Gu J; Xue S
    BMC Cell Biol; 2018 Nov; 19(1):24. PubMed ID: 30419807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.
    Guo C; Li Y; Gow CH; Wong M; Zha J; Yan C; Liu H; Wang Y; Burris TP; Zhang J
    J Biol Chem; 2015 Feb; 290(6):3666-79. PubMed ID: 25519902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-repression of NFκB pathway mediated by PPARγ improves vascular endothelium insulin resistance.
    Kong Y; Gao Y; Lan D; Zhang Y; Zhan R; Liu M; Zhu Z; Zeng G; Huang Q
    J Cell Mol Med; 2019 Jan; 23(1):216-226. PubMed ID: 30398029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death.
    Leitao BB; Jones MC; Brosens JJ
    FASEB J; 2011 Oct; 25(10):3416-25. PubMed ID: 21676946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinopodium chinense Attenuates Palmitic Acid-Induced Vascular Endothelial Inflammation and Insulin Resistance through TLR4-Mediated NF-
    Shi X; Wang S; Luan H; Tuerhong D; Lin Y; Liang J; Xiong Y; Rui L; Wu F
    Am J Chin Med; 2019; 47(1):97-117. PubMed ID: 30776912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of small ubiquitin-like modifier-1, nuclear receptor coreceptor, histone deacetylase 3, and peroxisome proliferator-activated receptor-γ in human adipose tissue.
    Finlin BS; Bodles-Brakhop AM; Yao-Borengasser A; Zhu B; Starnes CP; McGehee RE; Peterson CA; Kern PA; Rasouli N
    Metab Syndr Relat Disord; 2012 Aug; 10(4):312-7. PubMed ID: 22651256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
    Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
    J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
    Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
    Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIAS1 binds p300 and behaves as a coactivator or corepressor of the transcription factor c-Myb dependent on SUMO-status.
    Ledsaak M; Bengtsen M; Molværsmyr AK; Fuglerud BM; Matre V; Eskeland R; Gabrielsen OS
    Biochim Biophys Acta; 2016 May; 1859(5):705-18. PubMed ID: 27032383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorative effects of indomethacin at different concentrations on endothelial insulin resistance through two distinct pathways.
    Xian T; Gan Y; Lu Y; Wang M; Yuan W; Zhou Y; Chen J; Wang K; Xiong S; Huang Q
    Biomed Pharmacother; 2018 Oct; 106():1161-1168. PubMed ID: 30119183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Suppressor p14ARF Enhances IFN-γ-Activated Immune Response by Inhibiting PIAS1 via SUMOylation.
    Alagu J; Itahana Y; Sim F; Chao SH; Bi X; Itahana K
    J Immunol; 2018 Jul; 201(2):451-464. PubMed ID: 29848755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor γ in C2C12 myotubes.
    Chung SS; Ahn BY; Kim M; Kho JH; Jung HS; Park KS
    Biochem J; 2011 Jan; 433(1):155-61. PubMed ID: 20950277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
    Chanda A; Ikeuchi Y; Karve K; Sarkar A; Chandhoke AS; Deng L; Bonni A; Bonni S
    Cell Death Differ; 2021 Jan; 28(1):267-282. PubMed ID: 32770107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.